 dog bring bacon ow
report revenu consensu adj ep
 consensu companion anim ca segment oper
growth deliv yet offset declin livestock y/i
oper stay pt ow rate reiter thesi ztss
diversifi portfolio strong ca product continu deliv growth
simparica trio launch loom ahead eu/u influenc stock return
key point note revenu discuss increment net
cannib strengthen competit advantag parasiticid
us follow eu us still outsiz contributor also see signific
scope market expans lt trio core driver next year
see geograph expans major pet market australia brazil japan china
product new launch drove growth ca ca continu strong
perform us y/i oper growth
market driver dermatolog parasiticid includ simparica
stronghold new product like revolut proheart one inject
deliv month heartworm diseas prevent
speci shift livestock asf impact swine dairi hit poultri offset
poultri grew y/i oper partial offset y/i oper declin
swine driven asf epidem china mirror similar perform see
note rooster rescu reiter expect
revenu impact note ow comment larger asian swine produc
pork product start discuss better biosecur measur re-
herd strategi expect gradual process due natur
increas livestock product also work asf vaccin similar
uw would signific market although sever year away
valuat valu pt use pe multipl higher end
histor trade rang stabl defens growth downsid risk fx
headwind worsen asf global slowdown greater competit ca
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
overweight ow driven
new launch companion anim health
greater thrust toward biolog drug
unmet need chronic diseas pet also
expect continu effici alloc
capit done past value-ad
strong global growth faster anticip margin
expans earlier launch symparica trio valu
weak integr abaxi delay launch
symparica trio greater anticip competit
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
report result ahead
consensu driven strong
growth companion
anim segment improv
report revenu consensu adj ep
consensu companion anim segment grew y/i oper
offset declin food anim y/i oper
total revenu growth y/i gross margin
strong companion anim growth driven key product parasiticid includ
proheart revolut simparica well abaxi acquisit close late juli
ztss acquisit phoenix lab announc last week add grow
diagnost busi livestock pressur driven african swine fever china
partial off-set growth cattl poultri growth key market
narrow revenu guidanc increas ep guidanc manag narrow
revenu guidanc rais adjust ep
base exchang rate late octob
narrow revenu increas ep guidanc
valu use pe multipl valu higher end
histor trade rang stabl defens growth expect multipl stay
intact compani continu deliv strong revenu earn growth risk
thesi includ downsid fx headwind usd strength higher-than-
anticip gener threat global macro slowdown increas incid
asf upsid acceler global growth value-ad
valu month pt
pe multiplehistor average multipl base per share barclay zoeti inc
balaji prasad md herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur issuer
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past month
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic issuer
within next month
fa barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
us regul
fb barclay bank plc and/or affili benefici own long posit class equiti secur issuer
calcul accord eu regul
fc barclay bank plc and/or affili benefici own short posit class equiti secur issuer
calcul accord eu regul
fd barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
south korean regul
gd one analyst fundament credit coverag team member household financi interest debt
equiti secur issuer
ge one analyst fundament equiti coverag team member household financi interest debt
equiti secur issuer
 issuer benefici own class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement issuer provis financi servic barclay bank plc and/or
